Top headlines of the week from Friday, April 11- Thursday, April 17, 2014.
By now, almost everyone has heard the big announcement from CVS/pharmacy that their stores will become tobacco-free by October 1. This is a significant milestone, and yet it’s just the latest chapter of a long story explains Bob Gordon, winner of Legacy’s 2013 Community Activist Award.
Google is not doing enough to stop online sales of illegal drugs and fake prescription medicines, according to a group of state attorneys general. The company says it disabled 4.6 million pharmaceutical or health supplement ads last year.
Occasional marijuana use may change the brain structure in young adults, a new study suggests. Marijuana may cause changes related to motivation, emotion and reward.
The private equity firm Bain Capital recently took over the largest chain of substance treatment facilities in Massachusetts, The Boston Globe reports. Bain, which usually makes investments in brand-name companies such as Dunkin’ Donuts, sees treating addiction as big business.
Massachusetts cannot ban the new pure hydrocodone drug Zohydro ER (extended release), a federal judge said Monday. The company that makes the drug, Zogenix, argued in a lawsuit that the ban is unconstitutional, according to The Wall Street Journal.
Almost one-quarter of pregnant women enrolled in Medicaid in 2007 filled a prescription for opioids, a new study finds. The risks of opioids to a developing fetus are largely unknown, The New York Times reports.
A bipartisan group of senators has formed to fight prescription drug abuse, according to The Hill. The group will look for innovative solutions to opioid abuse.
E-cigarette makers are targeting young people with free samples distributed at music and sporting events, according to an investigation by 11 Democratic members of the U.S. House and Senate. The companies are also running radio and television ads during programs aimed at young people, the lawmakers said.
Reproduction in whole or in part of this publication is strictly prohibited without prior consent. Photographic rights remain the property of Join Together and the Partnership for Drug-Free Kids. For reproduction inquiries, please e-mail email@example.com.